Drug Profile
Estradiol/levonorgestrel transdermal - Labtec
Alternative Names: Estradiol + levonorgestrel transdermal - Labtec; Levonor TDS; Levonorgestrel + estradiol transdermal - Labtec; Levonorgestrel/estradiol transdermal - LabtecLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Labtec
- Developer tesa Labtec
- Class Estradiol congeners; Estrenes; Hormonal replacements; Norpregnanes; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Menopausal syndrome
Most Recent Events
- 02 Jan 2007 Registered for Menopausal syndrome in the European Union under the mutual recognition procedure with Sweden as the reference member state (Transdermal)
- 11 May 2006 This product is still under review for approval in the European Union
- 31 Mar 2004 This product has been filed for approval within the European Union through the mutual recognition procedure; Sweden is acting as the reference member state